Experiments in the latest oncology research regarding PRKCDBP as a transcriptional target of TNF‐α demonstrated that low expression of PRKCDBP forebode poor prognosis in tumour patients, including those with lung adenocarcinoma.42, 43. This evidence concerns the gene CAVIN3 and lung adenocarcinoma.